Sue Ward BA (Durham)

Ward2

HEDS, ScHARR
University of Sheffield
Regent Court, 30 Regent Street
Sheffield, S1 4DA

Office: 1018

Tel: (+44) (0)114 222 0816
Fax: (+44) (0)114 222 0749

E-mail: s.e.ward@sheffield.ac.uk

ORCiD: 0000-0002-3344-0913

Biography 

I graduated with an Economics degree from Durham University. After working in marketing and operational research with the electricity industry I moved to the University of Sheffield in 1994. My main area of interest is economic evaluation in health care, with a particular focus on economic modelling of cancer therapies.

Economic evaluation in cancer
I have been a major contributor to the HEDS section input to rapid review projects in the cancer field for the National Institute for Health and Clinical Excellence (NICE), including the cost effectiveness of gemcitabine in pancreatic cancer, oral drugs for advanced colorectal cancer and hormonal therapies and taxanes for early breast cancer. I have also led a series of economic evaluations of new guidance for the management and treatment of a range of cancers (including upper gastro-intestinal cancers, haematological, cancers and breast cancer) for the Department of Health in England and Wales, along with an economic evaluation of the recent guidance on supportive and palliative care. In addition I have been involved in a series of industry funded projects for cancer treatment in the field of chronic myeloid leukaemia, gastro-intestinal stromal tumours and renal cell carcinoma and worked on a HTA project relating to the cost effectiveness of enhanced imaging techniques for assessment of axillary lymph node metastases.

Coronary heart disease
Developing on work undertaken in 1997 and 1998 on the roles of statins in coronary heart disease and the development of a decision support tool for evaluation of alternative policies on HMG Co-A Reductase Inhibitor (Statin) prescribing, I led a Health Technology Assessment for statins in the prevention of cardiovascular events.

Work in other disease areas
I have also managed a number of projects in non-cancer related areas, including a series of industry-funded projects evaluating the use of a new treatment for Irritable Bowel Syndrome.

Research interests

My research interests are:

  • Modelling in health care
  • Economic evaluation of cancer therapies
  • Economic evaluation of therapies for the prevention of coronary heart disease

Teaching interests

I deliver lectures on the critical appraisal of economic evaluations on the MSc Health Economics and Decision Modelling.

Current projects

I am currently working on the following projects:

  • Cost effectiveness of second line treatments for chronic myeloid leukaemia
  • Cost effectiveness of lapatinib in breast cancer
  • The economic impact of avoidable admissions in palliative care
  • Systematic review of utilities for breast cancer

Extended List of Publications

Journal articles

Conference proceedings papers